Discover how AI, automation, and next-generation DMTA workflows are accelerating drug discovery with expert insights from TTP ...

Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...

A new fully automated in vivo screening system (AISS) has been developed to transform drug evaluation by enabling rapid, precise, and non-invasive multi-organ imaging in zebrafish. Integrating cutting ...

With artificial intelligence, scientists can design increasingly complex small molecule structures. Automation is critical for transforming these compounds from designs on a screen into actual ...

The complexity of antibody-drug conjugates (ADCs) demands equally sophisticated analytical strategies. Researchers must navigate fragmented workflows, manual sample preparation, and experimental ...

When the first computer bug was discovered in 1947, it was quite literally a moth that had become trapped inside a system at Harvard University that was disrupting the electronics. At that time, the ...